1[1]Ramet M,Haataja R,Marttila R,et al.Allelic association surfactant protein A genes with respiratory distress syndrome.Biol Neonate,2000;77(Suppl 1):21
2[2]Cho K,Matsuda T,Okajima S,et al.Prediction of respiratory distress syndrome by the level of pulmonary surfactant protein A in cord blood sera.Biol Neonate,2000;77(2):83
3[3]Crowley P,Chalmers I,Keirse M.The effects of cortisteroid adminiistration before preterm delivery:an overview of the evidence from controlled trials.Br J Obstet Gynecol,1990;97(1):11
4[4]Ohki Y,Nako Y,Koizumi T,et al.The effects of aerosolized furosemide in infants with chronic lung disease.Acta Paediatrica,1997;86(6):656
5[5]Avent ML,Gal P,Ransom JL,et al.The role of inhaled steroids in the treatment of bronchopulmonary dysplasia.Neonatal Network,1994;13(3):63
7Freed GE, Meny RG. Apnea of prematurity and risk for sudden infant death syndrome[J]. Pediatrics, 1999,104(2 Pt 1):297- 298.
8Lee TC, Charles B, Steer P, et al. Population pharmacokinetics of intravenous caffeine in nenonates with apnea of prematurity[J].Clin Pharmacol Ther, 1997,61(6):628- 640.
9Calhoun LK. Pharmacologic management of apnea of prematurity[J]. J Perinat Neonatal Nurs, 1996,9(4):56- 62.
